NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE
NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE: Offer reference number: CM/PHG/21/5639/00 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months) FIND A TENDER (FTS) Reference number: 2021/S 000-008845 Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 (19 months) LSNE region.
Buyer
NHS England
Value
£1,520
Published
27 Apr 2021
Closes
26 May 2021
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE
£1,520
NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE: Offer reference number: CM/PHG/21/5639/00 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months) FIND A TENDER (FTS) Reference number...
Delivery: United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
27 Apr 2021
Opportunity notice on Contracts Finder
Tender notice · Web page
Document No. 05a (ii) CM_PHG_21_5639_00 SELECTT Application
Not provided
Document No. 05a (ii) CM_PHG_21_5639_00 SELECTT Application
Link
Document No. 08 - Confidential information schedule
Not provided
Document No. 08 - Confidential information schedule
Link
Document No. 01 - Invitation to offer covering letter
Not provided
Document No. 01 - Invitation to offer covering letter
Link
Document No. 06 - Form of offer
Not provided
Document No. 06 - Form of offer
Link
Document No. 05a (i) Product Listing and Usage - Transition (CM_PHG_21_5639_00)
Not provided
Document No. 05a (i) Product Listing and Usage - Transition (CM_PHG_21_5639_00)
Link
Document No. 09 - Stability Data Requirements
Not provided
Document No. 09 - Stability Data Requirements
Link
Qualification Questionnaire - Transition 2021_2 - Pemetrexed Solution for Infusion LSNE
Not provided
Qualification Questionnaire - Transition 2021_2 - Pemetrexed Solution for Infusion LSNE
Link
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS
Not provided
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS
Link
Document No. 03 - Framework Agreement and Terms and Conditions
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions
Link
Document No. 02 - Terms of Offer
Not provided
Document No. 02 - Terms of Offer
Link
Document No. 07a - Quality control technical sheet
Not provided
Document No. 07a - Quality control technical sheet
Link
Contains public sector information licensed under the Open Government Licence v3.0.